> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# HHS to Appoint 2 New FDA Deputy Commissioners: CNBC
- URL: https://www.fdaweb.com/hhs-to-appoint-2-new-fda-deputy-commissioners-cnbc/
- Published: 2026-08-26T12:00:00.000Z
- Updated: 2026-09-14T12:05:42.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5161683

HHS is planning to name an FDA deputy commissioner for technology and a deputy commissioner for drugs, according to a CNBC report. The network [says](https://www.cnbc.com/2026/08/25/hhs-fda-leadership-roles-technology-drugs.html?ref=fdaweb.com) some anonymous sources in the Trump administration see the new appointments as a way to exert greater influence over the agency. Both of the new appointments would report directly to Trump’s pick for commissioner, **Heidi Overton**, when she is confirmed.

While CNBC was unable to learn who might be a candidate for the drug-oriented position, it reports that FDA senior advisor **Jared Seehafer**, described as a medical device industry veteran, is the leading candidate for the technology post. He is a co-founder and former CEO of the life-science software firm Enzyme and has been a venture capitalist.

HHS did not respond to multiple requests for comment from CNBC.